Verisante Technology, Inc. to Present at 2nd Emerging Medical Technologies (EMT) Summit
(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 11/10/14 -- . (TSX VENTURE: VRS)(OTCQX: VRSEF) (the "Company" or "Verisante"), a leader in cancer detection technology, today announced that Thomas Braun, President & CEO, will present at the upcoming Emerging Medical Technologies (EMT) Summit in San Francisco on November 11, 2014 at the Sofitel Hotel San Francisco Bay.
On November 10 - 12th, at the Emerging Medical Technologies (EMT) Summit, active medical device venture capitalists and top business development executives from the medtech industry will be in attendance to preview CEO presentations from 75 innovative emerging medical technology companies. They will have access there to Verisante''s management through a corporate presentation and small group meetings.
The organizer of this event is Life Science Intelligence (LSI). For more information please visit .
About Verisante Technology, Inc.
committed to . and the utilize a proprietary cancer detection platform, while the operating software and probe technology are unique to each device. The cancer detection platform was developed by the BC Cancer Agency and tested and refined at the Skin Care Centre at Vancouver General Hospital. This exclusive platform technology allows Verisante to develop and offer a range of compact, for many of the most common cancers. Aura™ has been approved for sale in Canada, Europe and Australia. Core™ has not yet been approved for sale.
Verisante Aura™ was awarded the 2014 North American Technology Innovation of the Year Award for In Vivo Cancer Detection by Frost & Sullivan, Popular Science Magazine''s "" for 2011, awarded a for Innovation in Photonics and an for Excellence in Innovation in 2013. Verisante Core™ was named one of the of 2011 by the Canadian Cancer Society.
The TSX Venture Exchange has neither approved nor disapproved of the contents of this press release. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
Forward Looking Statements
This release contains forward-looking statements, including, but not limited to, statements regarding the future commercialization of medical devices, the market demand for these products and the proprietary protections the Company will obtain with regard to the technology, all of which statements are subject to market risks, and the possibility that the Company will not be able to obtain patent protection or obtain sufficient customer demand. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.
Contacts:
Verisante Technology, Inc.
Thomas Braun
President & CEO
(604) 605-0507
YouTube:
Twitter:
Facebook:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 10.11.2014 - 09:00 Uhr
Sprache: Deutsch
News-ID 1316914
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
VANCOUVER, BRITISH COLUMBIA
Phone:
Kategorie:
Hospitals, Facilities and Providers
Anmerkungen:
Diese Pressemitteilung wurde bisher 177 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Verisante Technology, Inc. to Present at 2nd Emerging Medical Technologies (EMT) Summit
"
steht unter der journalistisch-redaktionellen Verantwortung von
Verisante Technology, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
